{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:19:57Z","timestamp":1794946797844,"version":"4.9.1"},"reference-count":21,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,10,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The POEMS syndrome is associated with elevated vascular endothelial growth factor (VEGF) levels. Several studies have compared serum VEGF levels between POEMS patients and other disease entities showing higher serum VEGF in POEMS syndrome; however, it is unknown whether serum levels are reliable and reproducible given variable platelet release of VEGF. We therefore compared plasma levels of VEGF in 29 patients with POEMS syndrome with those of other disorders (n = 76). We demonstrated that plasma VEGF levels are useful in differentiating POEMS from other plasma cell dyscrasias, neuropathic processes, and multisystem illnesses. Plasma VEGF is also useful in monitoring disease activity after treatment and correlates with clinical improvements better than hematologic response.<\/jats:p>","DOI":"10.1182\/blood-2011-06-362392","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T12:09:34Z","timestamp":1314878974000},"page":"4663-4665","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":205,"title":["The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome"],"prefix":"10.1182","volume":"118","author":[{"given":"Anita","family":"D'Souza","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne R.","family":"Hayman","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Buadi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Mauermann","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Q.","family":"Lacy","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morie A.","family":"Gertz","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Greipp","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Lust","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Russell","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Zeldenrust","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dingli","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Witzig","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111806561768400_B1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.blre.2007.07.004","article-title":"POEMS syndrome.","volume":"21","author":"Dispenzieri","year":"2007","journal-title":"Blood Rev"},{"issue":"9002","key":"2019111806561768400_B2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(96)91261-1","article-title":"Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome.","volume":"347","author":"Watanabe","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"2019111806561768400_B3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/art.1780400430","article-title":"Growth factors in POEMS syndrome: evidence for a marked increase in vascular endothelial growth factor.","volume":"40","author":"Soubrier","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2019111806561768400_B4","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V87.4.1458.bloodjournal8741458","article-title":"Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome.","volume":"87","author":"Gherardi","year":"1996","journal-title":"Blood"},{"issue":"8","key":"2019111806561768400_B5","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis.","volume":"128","author":"Scarlato","year":"2005","journal-title":"Brain"},{"issue":"11","key":"2019111806561768400_B6","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/01.wnl.0000344569.13496.ff","article-title":"Serum VEGF levels in POEMS and in immune-mediated neuropathies.","volume":"72","author":"Nobile-Orazio","year":"2009","journal-title":"Neurology"},{"issue":"11","key":"2019111806561768400_B7","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4","article-title":"Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome.","volume":"21","author":"Watanabe","year":"1998","journal-title":"Muscle Nerve"},{"issue":"12","key":"2019111806561768400_B8","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2169\/internalmedicine.42.1240","article-title":"Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome.","volume":"42","author":"Tokashiki","year":"2003","journal-title":"Intern Med"},{"issue":"4","key":"2019111806561768400_B9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/cs0940395","article-title":"Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease.","volume":"94","author":"Webb","year":"1998","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"2019111806561768400_B10","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/bjc.1998.158","article-title":"Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.","volume":"77","author":"Banks","year":"1998","journal-title":"Br J Cancer"},{"issue":"2","key":"2019111806561768400_B11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00280-006-0403-6","article-title":"Challenges for patient selection with VEGF inhibitors.","volume":"60","author":"Longo","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"2019111806561768400_B12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1191\/0961203302lu131oa","article-title":"Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and anti-phospholipid antibody syndrome.","volume":"11","author":"Navarro","year":"2002","journal-title":"Lupus"},{"issue":"11","key":"2019111806561768400_B13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1046\/j.1365-4362.2003.01688.x","article-title":"Vascular endothelial growth factors are increased and associated with disease activity in patients with Behcet's syndrome.","volume":"42","author":"Cekmen","year":"2003","journal-title":"Int J Dermatol"},{"issue":"1","key":"2019111806561768400_B14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/157016110790226606","article-title":"Role of vascular endothelial growth factor in kidney disease.","volume":"8","author":"Doi","year":"2010","journal-title":"Current Vasc Pharmacol"},{"issue":"21","key":"2019111806561768400_B15","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1212\/01.wnl.0000323811.42080.a4","article-title":"Neurological improvement after peripheral blood stem cell transplantation in POEMS syndrome.","volume":"71","author":"Kuwabara","year":"2008","journal-title":"Neurology"},{"issue":"11","key":"2019111806561768400_B16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/jnnp.2008.150177","article-title":"Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.","volume":"79","author":"Kuwabara","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2019111806561768400_B17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archdermatol.2010.100","article-title":"Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome.","volume":"146","author":"Barete","year":"2010","journal-title":"Arch Dermatol"},{"issue":"24","key":"2019111806561768400_B18","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1182\/blood-2010-12-328112","article-title":"Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS.","volume":"117","author":"Li","year":"2011","journal-title":"Blood"},{"issue":"18","key":"2019111806561768400_B19","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1182\/blood-2010-10-299487","article-title":"Consensus recommendations for the uniform reporting of clinical trials: reports of the International Myeloma Workshop Consensus Panel 1.","volume":"117","author":"Rajkumar","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019111806561768400_B20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/mus.21872","article-title":"Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias.","volume":"43","author":"Briani","year":"2011","journal-title":"Muscle Nerve"},{"key":"2019111806561768400_B21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/1097-4598(200007)23:7<1051::AID-MUS7>3.0.CO;2-V","article-title":"Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome.","volume":"23","author":"Hashiguchi","year":"2000","journal-title":"Muscle Nerve"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/17\/4663\/1463801\/zh804311004663.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/17\/4663\/1463801\/zh804311004663.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T11:57:30Z","timestamp":1574078250000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/17\/4663\/29066\/The-utility-of-plasma-vascular-endothelial-growth"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,27]]},"references-count":21,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2011,10,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-06-362392","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,27]]}}}